Analysis of prognosis and clinical risk factors in elderly peritoneal dialysis patients with peritonitis

  • ZHANG Chunyan ,
  • ZHANG Qianying ,
  • YANG Li ,
  • CUI Yan ,
  • XU Tian ,
  • WANG Zhaohui ,
  • REN Hong ,
  • HUANG Xiaomin
Expand
  • Department of Nephrology; Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received date: 2024-12-19

  Revised date: 2025-06-17

  Online published: 2026-06-15

Copyright

Copyright © 2026 Journal of Internal Medicine Concepts & Practice. All rights reserved.

Abstract

Objective To analyze the clinical risk factors and prognosis of elderly peritoneal dialysis patients with peritonitis. Methods A retrospective analysis was conducted on the data of patients who underwent peritoneal dialysis and developed peritonitis at this peritoneal dialysis center between January 2020 and November 2022. Patients were divided into 2 groups according to their age at peritonitis onset: an elderly peritonitis group (age≥65) and a non-elderly peritonitis group (age<65). General information and peritonitis-related data were collected, and the clinical risk factors and prognosis of peritonitis between the 2 groups were compared. Results A total of 62 patients with peritonitis were enrolled, including 26 in the elderly peritonitis group, where the median age was 71 (range 65-88), 12 patients were male (46.2%), and 5 patients had diabetic nephropathy complicated by diabetes mellitus (19.2%); 36 in the non-elderly peritonitis group, where the median age was 48 (range 26-63), 23 patients were male (63.9%), and 5 patients had diabetic nephropathy complicated by diabetes mellitus (13.9%). The elderly peritonitis group exhibited a worse prognosis than the non-elderly peritonitis group (mortality 30.8% vs. 2.8%; technique failure rates 23.1% vs. 16.7%, P=0.004). The elderly peritonitis group had a higher proportion of patients with education level of middle school or below (72.2% vs. 53.8%, P=0.038), a higher proportion requiring caregivers (100% vs. 83.3%, P=0.035), a higher frequency of operator changes (38.5% vs. 11.1%, P=0.011), longer initial training time (4 d vs. 3 d, P<0.01), and longer dialysis duration (70.5 months vs 29.5 months, P=0.002). The non-elderly peritonitis patients had better nutritional status: both normalized protein catabolic rate (nPCR) (0.90 vs. 0.79, P=0.007) and plasma albumin (34.78 g/L vs. 30.77 g/L, P<0.01) were higher. The elderly peritonitis group had lower levels of blood creatinine (872.42 μmol/L vs. 1053.69μmol/L, P<0.01), blood uric acid (345.0 μmol/L vs. 372.0 μmol/L, P=0.023), blood potassium (3.65 mmol/L vs. 3.95 mmol/L, P=0.012), blood phosphorus (1.54 mmol/L vs. 1.80 mmol/L, P=0.022), intact parathyroid hormone (iPTH) (227.2 pg/mL vs. 414.0 pg/mL, P=0.037), and 25-hydroxyvitamin D3 (17.95 nmol/L vs. 22.57 nmol/L, P=0.007). Conclusions Elderly patients with peritonitis had a poorer prognosis. Compared with younger patients with peritonitis, elderly patients had lower education levels, longer dialysis duration, worse nutritional status, poorer operational ability, and a greater need for caregivers.

Cite this article

ZHANG Chunyan , ZHANG Qianying , YANG Li , CUI Yan , XU Tian , WANG Zhaohui , REN Hong , HUANG Xiaomin . Analysis of prognosis and clinical risk factors in elderly peritoneal dialysis patients with peritonitis[J]. Journal of Internal Medicine Concepts & Practice, 2026 , 21(02) : 132 -137 . DOI: 10.16138/j.1673-6087.2026.02.05

References

[1] 安玲, 刘文花, 吉栋德, 等. 腹膜透析腹膜炎的影响因素及短期预后分析[J]. 中国现代医学杂志,2020,30(13):51-55.
  An L, Liu WH, Ji DD, et al. Analysis of the risk factors and short-term prognosis of peritoneal dialysis peritonitis[J]. Chin J Mod Med,2020,30(13):51-55.
[2] Li PK, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendation: 2022 update on prevention and treatment[J]. Perit Dial Int,2022,42(2):110-153.
[3] Li PK, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment[J]. Perit Dial Int,2016,36(5):481-508.
[4] Li PKT, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations:2022 update on prevention and treatment. Perit Dial Int. 2022;42(2):110-153.
[5] Harlacher E, Wollenhaupt J, Baaten CCFMJ, et al. Impact of uremic toxins on endothelial dysfunction in chronic kidney disease:a systematic review[J]. Int J Mol Sci. 2022 Jan 4;23(1):531.
[6] 薛丹丹, 李相, 马小芬, 等. 细胞焦亡在腹膜纤维化发生、发展中作用的研究进展[J]. 中国医师杂志,2023,25(6):958-960.
  Xue DD, Li X, Ma XF, et al. Research progress on the role of pyroptosis in the occurrence and development of peritoneal fibrosis[J]. J Chin Physician,2023,25(6):958-960.
[7] 梁琦晨, 赵慧萍, 武蓓, 等. 不同透析龄腹膜透析患者首次腹膜透析相关性腹膜炎的临床特征及预后[J]. 中国血液净化,2022,21(11):790-794.
  Liang QC, Zhao HP, Wu B, et al. Clinical characteristics and prognosis of the first episode of peritoneal dialysis-associated peritonitis in patients with different peritoneal dialysis duration[J]. Chin J Blood Purif,2022,21(11):790-794.
[8] De Simone B, Chouillard E, Podda M, et al. The 2023 WSES guidelines on the management of trauma in elderly and frail patients[J]. World J Emerg Surg,2024,19(1):18.
[9] 沈霞, 何浩, 张慧, 等. 上海市单中心儿童腹膜透析导管污染事件的横断面调查[J]. 中国循证儿科杂志,2025,20(1):53-56.
  Shen X, He H, Zhang H, et al. Catheter contamination events on peritoneal dialysis children in a single center in Shanghai: a cross-sectional survey[J]. Chin J Evid Based Pediatr,2025,20(1):53-56.
[10] 林小燕, 林建雄, 朱丽娜, 等. 腹膜透析患者换液操作前准备情况与腹膜炎发生的相关性分析[J]. 中国血液净化,2019,18(9):607-610.
  Lin XY, Lin JX, Zhu LN, et al. The correlation between preparation before fluid exchange and peritoneal dialysis-related peritonitis[J]. Chin J Blood Purif,2019,18(9):607-610.
[11] Jiang C, Zheng Q. Outcomes of peritoneal dialysis in elderly vs non-elderly patients:a systemic review and meta-analysis[J]. PLoS One. 2022, 17(2):e0263534.
[12] 白若靖, 郭军. 免疫衰老对老年人群健康影响的研究进展[J]. 国际免疫学杂志,2025,48(1):86-90.
  Bai RJ, Guo J. Research progress on the impact of immunosenescence on the health of the elderly population[J]. Int J Immunol,2025,48(1):86-90.
[13] National Kidney Foundation K/DOQI Work Group. The National Kidney Foundation K/DOQI clinical practice guidelines for dietary protein intake for chronic dialysis patients[J]. Am J Kidney Dis, 2001, 38 (4 Suppl 1):S68-73.
[14] 中国营养学会. 中国居民膳食营养素参考摄入量(2023 版)[M]. 北京: 人民卫生出版社, 2023.
  Chinese Nutrition Society. Dietary reference intakes for China (2023 edition)[M]. Beijing:People's Medical Publishing House, 2023.
[15] 殷实, 殷华, 方向, 等. 高龄慢性病患者血浆白蛋白与前白蛋白水平和外周血细胞免疫功能的相关性研究[J]. 中国临床保健杂志,2017,20(4):337-340.
  Yin S, Yin H, Fang X, et al. Plasma albumin, prealbumin level and the correlation with the cellular immune function in peripheral blood cell from elderly inpatients with chronic diseases[J]. Chin J Clin Healthc,2017,20(4):337-340.
[16] Yang CY, Chen TW, Lin YP, et al. Determinants of catheter loss following continuous ambulatory peritoneal dialysis peritonitis[J]. Perit Dial Int,2008,28(4):361-370.
[17] Kiebalo T, Holotka J, Habura I, et al. Nutritional status in peritoneal dialysis: nutritional guidelines, adequacy and the management of malnutrition[J]. Nutrients,2020,12(6):1715.
[18] 张小美, 叶慧, 杨芳, 等. 维生素D及其信号通路在疾病中的作用研究进展[J]. 药物流行病学杂志,2025,34(4):456-466.
  Zhang XM, Ye H, Yang F, et al. Research progress on the role of vitamin D and its signaling pathway in disease development[J]. Chin J Pharmacoepidemiol,2025,34(4):456-466.
[19] 刘海洋, 刘虹. 腹膜透析与维生素D的研究进展[J]. 中国血液净化,2017,16(4):148-151.
  Liu HY, Liu H. The research progress of vitamin D and peritoneal dialysis[J]. Chin J Blood Purif,2017,16(4):148-151.
[20] 刘小菁, 岳凌菊, 刘永泉, 等. 单中心腹膜透析相关性腹膜炎的临床分析[J]. 中国血液净化, 2017, 16(4): 179-182.
  Liu CJ, Yue LJ, Liu YQ, et al. Clinical analysis of peritoneal dialysis-related peritonitis in a single center[J]. 2017, 16(4):179-182.
Outlines

/